BRPI0906444A2 - Compostos de 4-piridinona e seu uso para câncer - Google Patents

Compostos de 4-piridinona e seu uso para câncer

Info

Publication number
BRPI0906444A2
BRPI0906444A2 BRPI0906444-3A BRPI0906444A BRPI0906444A2 BR PI0906444 A2 BRPI0906444 A2 BR PI0906444A2 BR PI0906444 A BRPI0906444 A BR PI0906444A BR PI0906444 A2 BRPI0906444 A2 BR PI0906444A2
Authority
BR
Brazil
Prior art keywords
cancer
pyridinone compounds
pyridinone
compounds
Prior art date
Application number
BRPI0906444-3A
Other languages
English (en)
Inventor
Robert M Borzilleri
Zhen-Wei Can
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of BRPI0906444A2 publication Critical patent/BRPI0906444A2/pt
Publication of BRPI0906444A8 publication Critical patent/BRPI0906444A8/pt
Publication of BRPI0906444B1 publication Critical patent/BRPI0906444B1/pt
Publication of BRPI0906444B8 publication Critical patent/BRPI0906444B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0906444A 2008-01-23 2009-01-22 compostos de 4-piridinona, composição farmacêutica que os compreende, bem como uso dos mesmos BRPI0906444B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2284808P 2008-01-23 2008-01-23
US61/022,848 2008-01-23
PCT/US2009/031649 WO2009094417A1 (en) 2008-01-23 2009-01-22 4-pyridinone compounds and their use for cancer

Publications (4)

Publication Number Publication Date
BRPI0906444A2 true BRPI0906444A2 (pt) 2015-07-14
BRPI0906444A8 BRPI0906444A8 (pt) 2020-02-27
BRPI0906444B1 BRPI0906444B1 (pt) 2021-03-16
BRPI0906444B8 BRPI0906444B8 (pt) 2021-05-25

Family

ID=40637826

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0906444A BRPI0906444B8 (pt) 2008-01-23 2009-01-22 compostos de 4-piridinona, composição farmacêutica que os compreende, bem como uso dos mesmos

Country Status (21)

Country Link
US (2) US8124768B2 (pt)
EP (1) EP2235002B1 (pt)
JP (1) JP5314050B2 (pt)
KR (1) KR101596527B1 (pt)
CN (1) CN101977906B (pt)
AU (1) AU2009206440B2 (pt)
BR (1) BRPI0906444B8 (pt)
CA (1) CA2713111C (pt)
CO (1) CO6230986A2 (pt)
CY (1) CY1114140T1 (pt)
DK (1) DK2235002T3 (pt)
EA (1) EA017736B1 (pt)
ES (1) ES2398335T3 (pt)
HR (1) HRP20130040T1 (pt)
IL (1) IL207212A (pt)
NZ (1) NZ586630A (pt)
PL (1) PL2235002T3 (pt)
PT (1) PT2235002E (pt)
SI (1) SI2235002T1 (pt)
WO (1) WO2009094417A1 (pt)
ZA (1) ZA201005248B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2740746A1 (en) 2008-10-14 2010-04-22 Ning Xi Compounds comprising a spiro-ring and and methods of use
EP2408300B1 (en) 2009-03-21 2016-05-11 Sunshine Lake Pharma Co., Ltd. Amino ester derivatives, salts thereof and methods of use
US8569319B2 (en) 2010-04-29 2013-10-29 Deciphera Pharmaceuticals, LLS Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
RU2477723C2 (ru) 2011-06-16 2013-03-20 Общество С Ограниченной Ответственностью "Фьюжн Фарма" Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
MY165215A (en) 2012-01-31 2018-03-09 Daiichi Sankyo Co Ltd Pyridone derivatives
JP6342392B2 (ja) 2012-07-28 2018-06-13 カリター・サイエンシーズ・エルエルシー 置換型ピラゾロン化合物及び使用方法
US8975282B2 (en) 2012-07-28 2015-03-10 Sunshine Lake Pharma Co., Ltd. Substituted pyrazolone compounds and methods of use
US9102624B2 (en) * 2012-08-23 2015-08-11 Boehringer Ingelheim International Gmbh Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
US20140057920A1 (en) * 2012-08-23 2014-02-27 Boehringer Ingelheim International Gmbh Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
US20140057926A1 (en) 2012-08-23 2014-02-27 Boehringer Ingelheim International Gmbh Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
TWI690525B (zh) 2014-07-07 2020-04-11 日商第一三共股份有限公司 具有四氫吡喃基甲基之吡啶酮衍生物及其用途
CN105153026B (zh) * 2015-08-21 2018-02-02 江西科技师范大学 含联芳基酰胺结构的索拉非尼衍生物及其制备方法和应用
CA3125559A1 (en) * 2019-01-03 2020-07-09 Array Biopharma Inc. Quinoline compounds as inhibitors of tam and met kinases
CN117355533A (zh) * 2021-06-22 2024-01-05 株式会社Lg化学 作为蛋白激酶抑制剂的新型化合物
TWI822140B (zh) * 2021-06-24 2023-11-11 南韓商Ｌｇ化學股份有限公司 作為ｒｏｎ抑制劑之新穎吡啶衍生物化合物
WO2024067783A1 (zh) * 2022-09-28 2024-04-04 上海济煜医药科技有限公司 含磷类化合物及其制备方法和医药应用
CN117180289A (zh) * 2023-10-25 2023-12-08 南京医科大学 麦他替尼胺丁三醇联合pd-l1抗体在制备治疗黑色素瘤药物中的应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0430885A3 (en) 1989-12-01 1991-11-06 Ciba-Geigy Ag Anthelmintical compounds
WO1997017329A1 (en) 1995-11-07 1997-05-15 Kirin Beer Kabushiki Kaisha Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
WO1999065867A1 (en) 1998-06-17 1999-12-23 Du Pont Pharmaceuticals Company Cyclic hydroxamic acids as metalloproteinase inhibitors
US6355660B1 (en) 1999-07-20 2002-03-12 Dow Agrosciences Llc Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
JP2003528806A (ja) 1999-07-20 2003-09-30 ダウ・アグロサイエンス・エル・エル・シー 殺菌・殺カビ性複素環式芳香族アミドおよびそれらの組成物、使用および製造方法
SK3822002A3 (en) 1999-09-21 2002-10-08 Astrazeneca Ab Quinazoline derivatives, process for the preparation thereof and their use
WO2001070753A1 (en) * 2000-03-22 2001-09-27 Merck Frosst Canada & Co. Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors
FR2812633A1 (fr) 2000-08-04 2002-02-08 Aventis Cropscience Sa Derives de phenyl(thio)urees et phenyl(thio)carbamates fongicides
SE0102384D0 (sv) 2001-07-03 2001-07-03 Pharmacia Ab New compounds
US20050038035A1 (en) 2001-11-28 2005-02-17 Hisashi Takasugi Heterocyclic amide compounds as apolipoprotein b inhibitors
SE0302487D0 (sv) 2003-09-18 2003-09-18 Astrazeneca Ab Novel compounds
JP2005263787A (ja) 2004-02-17 2005-09-29 Ishihara Sangyo Kaisha Ltd アミド系化合物又はその塩、並びにそれらを含有するサイトカイン産生抑制剤
US7459562B2 (en) * 2004-04-23 2008-12-02 Bristol-Myers Squibb Company Monocyclic heterocycles as kinase inhibitors
AU2005245386B2 (en) 2004-05-07 2008-11-27 Amgen Inc. Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
US7439246B2 (en) 2004-06-28 2008-10-21 Bristol-Myers Squibb Company Fused heterocyclic kinase inhibitors
US20050288290A1 (en) 2004-06-28 2005-12-29 Borzilleri Robert M Fused heterocyclic kinase inhibitors
US7432373B2 (en) 2004-06-28 2008-10-07 Bristol-Meyers Squibb Company Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
JO2787B1 (en) 2005-04-27 2014-03-15 امجين إنك, Alternative amide derivatives and methods of use
US7732613B2 (en) 2005-09-14 2010-06-08 Bristol-Myers Squibb Company Met kinase inhibitors
WO2007035428A1 (en) 2005-09-15 2007-03-29 Bristol-Myers Squibb Company Met kinase inhibitors
US7348325B2 (en) 2005-11-30 2008-03-25 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
US8558000B2 (en) 2008-01-23 2013-10-15 Bristol-Myers Squibb Company 4-pyridinone compounds and their use for cancer

Also Published As

Publication number Publication date
JP2011510087A (ja) 2011-03-31
CO6230986A2 (es) 2010-12-20
US20110034416A1 (en) 2011-02-10
SI2235002T1 (sl) 2013-06-28
BRPI0906444B8 (pt) 2021-05-25
CY1114140T1 (el) 2016-07-27
PL2235002T3 (pl) 2013-04-30
CA2713111C (en) 2015-06-30
US8124768B2 (en) 2012-02-28
IL207212A0 (en) 2010-12-30
KR20100103636A (ko) 2010-09-27
ES2398335T3 (es) 2013-03-15
NZ586630A (en) 2011-12-22
IL207212A (en) 2015-01-29
ZA201005248B (en) 2011-09-28
HK1143157A1 (en) 2010-12-24
CN101977906A (zh) 2011-02-16
KR101596527B1 (ko) 2016-02-22
DK2235002T3 (da) 2013-03-11
CA2713111A1 (en) 2009-07-30
EA017736B1 (ru) 2013-02-28
WO2009094417A1 (en) 2009-07-30
AU2009206440B2 (en) 2013-08-15
AU2009206440A1 (en) 2009-07-30
BRPI0906444A8 (pt) 2020-02-27
EP2235002A1 (en) 2010-10-06
JP5314050B2 (ja) 2013-10-16
EA201001196A1 (ru) 2011-02-28
PT2235002E (pt) 2013-01-30
HRP20130040T1 (hr) 2013-02-28
CN101977906B (zh) 2014-11-05
US20120114643A1 (en) 2012-05-10
EP2235002B1 (en) 2012-11-21
US8258118B2 (en) 2012-09-04
BRPI0906444B1 (pt) 2021-03-16

Similar Documents

Publication Publication Date Title
BR112012005807A2 (pt) materiais expansíveis e mpetodos para uso
BRPI1012533A2 (pt) composto de piradazinona e uso do mesmo
BR112012001797A2 (pt) composto bicíclico e uso do mesmo para propósitos médicos
BRPI0821668A2 (pt) Uso
BRPI1014572A2 (pt) imidazoprazinas para uso como inibidores de cinase
BRPI0810882A2 (pt) Derivados de ftalazinona e seu uso como medicamento para tratar câncer
SMT201500218B (it) Composti aril-fenil-solfonammido-cicloalchile e loro uso
BRPI1013432A2 (pt) derivado de indolizina e uso do mesmo para propósitos médicos
BRPI0914536A2 (pt) tiadiazoliloxifenilamidinas e o uso destas como fungicidas
HRP20180718T1 (hr) Oligopeptidni spojevi i njihova upotreba
BRPI1007494A2 (pt) composto e uso do mesmo
PT2456889E (pt) Marcadores para o cancro do endométrio
BRPI0816372A2 (pt) Ácidos 6-fenilnicotínicos substituídos e seu uso
BRPI0907254A2 (pt) Combinação biocida para uso em aplicações agrícolas
BRPI1015367A2 (pt) imidazotiodiazois para uso como inibidores de cinase
BR112012030927A2 (pt) fosfaplatinas e seu uso para o tratamento de cânceres
BRPI0909016A2 (pt) anticorpos úteis para o tratamento do câncer
BRPI0922884A2 (pt) compostos para tratamento de câncer
BRPI0812040A2 (pt) Indicações para terapia de anti-il-i-beta
PT2235002E (pt) Compostos de 4-piridinona e a sua utilização para o tratamento do cancro
BRPI0919794A2 (pt) dispositivo para uso intracorpóreo, e, composto
BRPI0814231A2 (pt) Derivados de pleuromutilina e seu uso como antimicrobianos
EP2283862A4 (en) ANTITUMOR AGENT
BRPI1011036A2 (pt) uso
BRPI0920502A2 (pt) compostos cicloundecadepsipeptídeos e seu uso como medicamento

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/03/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/01/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF